Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MLTX
MLTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MLTX News
MoonLake Reports Phase 3 VELA Trial Results for HS Treatment
1d ago
Newsfilter
MoonLake Immunotherapeutics Reports Strong VELA Trial Results for Sonelokimab
1d ago
Yahoo Finance
MoonLake Reports Strong Phase 3 Results for Sonelokimab Treatment
1d ago
stocktwits
MoonLake's Sonelokimab Shows Promising Phase 3 Results for Hidradenitis Suppurativa
1d ago
seekingalpha
MoonLake Immunotherapeutics Set for Key Clinical Data Release
5d ago
stocktwits
MoonLake Immunotherapeutics Stock Outlook Remains Positive
Jun 09 2026
stocktwits
MoonLake CFO Sells Shares Amid Market Volatility
Jun 05 2026
NASDAQ.COM
MoonLake CFO Sells Shares Under 10b5-1 Plan
Jun 05 2026
Fool
Trump Rejects Iran's Revised Proposal Amid Geopolitical Tensions
May 11 2026
stocktwits
U.S. Stock Futures Decline as Oil Prices Exceed $100 Again
May 11 2026
stocktwits
MoonLake Receives FDA Approval for Drug Label Update
May 11 2026
stocktwits
MoonLake Achieves Positive Consensus with FDA on BLA Submission for Sonelokimab
May 10 2026
Newsfilter
CEO Jorge Santos da Silva Sells 150,000 Shares of MoonLake Immunotherapeutics
Apr 18 2026
Fool
CEO Jorge Santos da Silva Sells 150,000 Shares of MoonLake Immunotherapeutics
Apr 18 2026
NASDAQ.COM
BVF Partners Sells $62.96 Million in MoonLake Immunotherapeutics Shares
Apr 07 2026
Fool
BVF Sells 3.75 Million Shares of MoonLake Immunotherapeutics
Apr 07 2026
NASDAQ.COM
Show More News
